Loading stock data…
AVNS
$24.66+0.04 (+0.16%)
Market ClosedLast close May 1
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Avanos Medical, Inc. in the Healthcare sector is trading at $24.66. The stock is currently near its 52-week high of $24.75, remaining 87.7% above its 200-day moving average. Technical signals show overbought RSI of 98 and bearish MACD signal, explaining why AVNS maintains its current momentum and trend strength. The Whystock Score of 35/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Overbought levels (RSI 98) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$24.66
Potential Upside
5%
Whystock Fair Value$25.89
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.15B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.05
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-59.52%
Volume
Today's trading volume
992,037
Recent News
Nanox To Deploy 300 Nanox.ARC Systems in The U.S. Over 3 Years
By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said it started two new U.S. collaborations to position its digital tomosynthesis system Nanox.ARC across the country. The first partnership is with Howard Technology Solutions to utilize 300 Nanox.ARC over a period of three years, and the second will deploy the system in clinics and hospitals with […]
Is It Too Late To Consider Buying Avanos Medical (AVNS) After Its Recent Share Price Surge?
Investors may be asking whether Avanos Medical's current share price reflects its underlying value, or if the market is mispricing the stock. The share price recently closed at US$24.62, with returns of 73.6% over 7 days, 88.7% over 30 days, 120.2% year to date, and 98.1% over 1 year. Over longer periods, the 3 year and 5 year returns are declines of 20.5% and 45.2%, respectively. These recent moves sit against a longer history that includes weak multi year returns, which can influence how...
Nanox Continues Expanding Nanox.ARC in U.S. & Israel
By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) announced it signed two new partnerships to continue deploying its digital tomosynthesis system Nanox.ARC both nationally and globally. The first collaboration is with Digital X-Ray Imaging Inc. to market, install and support the imaging system across major health systems in Arkansas, including hospital networks in the Little […]
Avanos Stock Surged on $1.27 Billion AIP Buyout Deal at 72% Premium
AVNS stock jumps after agreeing to a $1.27B all-cash buyout by AIP at a 72% premium, offering shareholders immediate value and setting up a private-market shift.
AIP to acquire Avanos Medical for $1.27bn
After closing, Avanos will be private in Alpharetta, Georgia, and delist its shares from the NYSE.